Managing chronic whiplash associated pain with a combination of low-dose opioid (remifentanil) and NMDA-antagonist (ketamine)

European Journal of Pain

Volumn 11, Issue 7, 2007, Pages 719-732

  Lemming, Dag ^a,b   Sörensen, Jan ^a,b   Graven Nielsen, Thomas ^c   Lauber, Rolf ^d   Arendt Nielsen, Lars ^c   Gerdle, Björn ^a,b  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c AALBORG UNIVERSITY   (Denmark)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

Experimental pain; Ketamine; Neck pain; Pain assessment; Remifentanil; WAD

Indexed keywords

KETAMINE; PLACEBO; REMIFENTANIL;

ABNORMAL SENSATION; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLD SWEAT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPLOPIA; DIZZINESS; DOUBLE BLIND PROCEDURE; ELECTROSTIMULATION; FEMALE; HALLUCINATION; HEADACHE; HUMAN; MALE; NAUSEA; PAIN; PAIN THRESHOLD; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SEDATION; SIDE EFFECT; TACHYCARDIA; TIBIALIS ANTERIOR MUSCLE; VISUAL ANALOG SCALE; WHIPLASH INJURY; XEROSTOMIA;

ADULT; ANALGESICS, OPIOID; CHRONIC DISEASE; DRUG THERAPY, COMBINATION; ELECTRIC STIMULATION; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; KETAMINE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NECK PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; PIPERIDINES; PRESSURE; REACTION TIME; RECEPTORS, N-METHYL-D-ASPARTATE; SODIUM CHLORIDE; WHIPLASH INJURIES;

EID: 34547442386     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1016/j.ejpain.2006.11.002     Document Type: Article

References (44)

1. Arendt-Nielsen L., and Graven-Nielsen T. Central sensitization in fibromyalgia and other musculoskeletal disorders. Curr Pain Headache Rep 7 5 (2003) 355-361
2. Arendt-Nielsen L., Petersen-Felix S., Fischer M., Bak P., Bjerring P., and Zbinden A.M. The effect of N-methyl-d-aspartate antagonist (ketamine) on single and repeated nociceptive stimuli: a placebo-controlled experimental human study. Anesth Analg 81 1 (1995) 63-68
3. Arendt-Nielsen L., Andersen O.K., and Jensen T.S. Brief, prolonged and repeated stimuli applied to hyperalgesic skin areas: a psychophysical study. Brain Res 712 1 (1996) 165-167
4. Arendt-Nielsen L., Nielsen J., Petersen-Felix S., Schnider T.W., and Zbinden A.M. Effect of racemic mixture and the (S+)-isomer of ketamine on temporal and spatial summation of pain. Br J Anaesth 77 5 (1996) 625-631
5. Arendt-Nielsen L., Graven-Nielsen T., Svensson P., and Jensen T.S. Temporal summation in muscles and referred pain areas: an experimental human study. Muscle Nerve 20 10 (1997) 1311-1313
6. Banic B., Petersen-Felix S., Andersen O.K., et al. Evidence for spinal cord hypersensitivity in chronic pain after whiplash injury and in fibromyalgia. Pain 107 1-2 (2004) 7-15
7. Bell R., Eccleston C., and Kalso E. Ketamine as an adjuvant to opioids for cancer pain. Cochrane Database Syst Rev 1 (2003) CD003351
8. Bossard A.E., Guirimand F., Fletcher D., Gaude-Joindreau V., Chauvin M., and Bouhassira D. Interaction of a combination of morphine and ketamine on the nociceptive flexion reflex in human volunteers. Pain 98 1-2 (2002) 47-57
9. Cervero F., and Laird J.M. From acute to chronic pain: mechanisms and hypotheses. Prog Brain Res 110 (1996) 3-15
10. Chapman V., and Dickenson A.H. The combination of NMDA antagonism and morphine produces profound antinociception in the rat dorsal horn. Brain Res 573 2 (1992) 321-323
11. Coderre T.J., Katz J., Vaccarino A.L., and Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 52 3 (1993) 259-285
12. Curatolo M., Petersen-Felix S., Arendt-Nielsen L., Giani C., Zbinden A.M., and Radanov B.P. Central hypersensitivity in chronic pain after whiplash injury. Clin J Pain 17 4 (2001) 306-315
13. Dickenson A.H. Spinal cord pharmacology of pain. Br J Anaesth 75 2 (1995) 193-200
14. Domino E.F., Domino S.E., Smith R.E., et al. Ketamine kinetics in unmedicated and diazepam-premedicated subjects. Clin Pharmacol Ther 36 5 (1984) 645-653
15. Egan T.D., Lemmens H.J., Fiset P., et al. The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. Anesthesiology 79 5 (1993) 881-892
16. Eide P.K., Jorum E., Stubhaug A., Bremnes J., and Breivik H. Relief of post-herpetic neuralgia with the N-methyl-d-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo. Pain 58 3 (1994) 347-354
17. Farrar J.T., Young Jr. J.P., LaMoreaux L., Werth J.L., and Poole R.M. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94 2 (2001) 149-158
18. Feng N., Vollenweider F.X., Minder E.I., Rentsch K., Grampp T., and Vonderschmitt D.J. Development of a gas chromatography-mass spectrometry method for determination of ketamine in plasma and its application to human samples. Ther Drug Monit 17 1 (1995) 95-100
19. Graven-Nielsen T., and Arendt-Nielsen L. Peripheral and central sensitization in musculoskeletal pain disorders: an experimental approach. Curr Rheumatol Rep 4 4 (2002) 313-321
20. Graven-Nielsen T., Arendt-Nielsen L., Svensson P., and Jensen T.S. Quantification of local and referred muscle pain in humans after sequential i.m. injections of hypertonic saline. Pain 69 1-2 (1997) 111-117
21. Graven-Nielsen T., Aspegren Kendall S., Henriksson K.G., et al. Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients. Pain 85 3 (2000) 483-491
22. Kalso E., Edwards J.E., Moore R.A., and McQuay H.J. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 112 3 (2004) 372-380
23. Koelbaek Johansen M., Graven-Nielsen T., Schou Olesen A., and Arendt-Nielsen L. Generalised muscular hyperalgesia in chronic whiplash syndrome. Pain 83 2 (1999) 229-234
24. Lehner A.F., Almeida P., Jacobs J., et al. Remifentanil in the horse: identification and detection of its major urinary metabolite. J Anal Toxicol 24 5 (2000) 309-315
25. Lemming D., Sorensen J., Graven-Nielsen T., Arendt-Nielsen L., and Gerdle B. The responses to pharmacological challenges and experimental pain in patients with chronic whiplash-associated pain. Clin J Pain 21 5 (2005) 412-421
26. Luginbuhl M., Gerber A., Schnider T.W., Petersen-Felix S., Arendt-Nielsen L., and Curatolo M. Modulation of remifentanil-induced analgesia, hyperalgesia, and tolerance by small-dose ketamine in humans. Anesth Analg 96 3 (2003) 726-732 [table of contents]
27. Maixner W., Fillingim R., Sigurdsson A., Kincaid S., and Silva S. Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain: evidence for altered temporal summation of pain. Pain 76 1-2 (1998) 71-81
28. Minto C.F., Schnider T.W., Egan T.D., et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology 86 1 (1997) 10-23
29. Minto C.F., Schnider T.W., and Shafer S.L. Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application. Anesthesiology 86 1 (1997) 24-33
30. Nikolajsen L., Hansen C.L., Nielsen J., Keller J., Arendt-Nielsen L., and Jensen T.S. The effect of ketamine on phantom pain: a central neuropathic disorder maintained by peripheral input. Pain 67 1 (1996) 69-77
31. Plesan A., Hedman U., Xu X.J., and Wiesenfeld-Hallin Z. Comparison of ketamine and dextromethorphan in potentiating the antinociceptive effect of morphine in rats. Anesth Analg 86 4 (1998) 825-829
32. Price D.D., Long S., and Huitt C. Sensory testing of pathophysiological mechanisms of pain in patients with reflex sympathetic dystrophy. Pain 49 2 (1992) 163-173
33. Schulte H., Graven-Nielsen T., Sollevi A., Jansson Y., Arendt-Nielsen L., and Segerdahl M. Pharmacological modulation of experimental phasic and tonic muscle pain by morphine, alfentanil and ketamine in healthy volunteers. Acta Anaesthesiol Scand 47 8 (2003) 1020-1030
34. Sethna N.F., Liu M., Gracely R., Bennett G.J., and Max M.B. Analgesic and cognitive effects of intravenous ketamine-alfentanil combinations versus either drug alone after intradermal capsaicin in normal subjects. Anesth Analg 86 6 (1998) 1250-1256
35. Shimoyama N., Shimoyama M., Inturrisi C.E., and Elliott K.J. Ketamine attenuates and reverses morphine tolerance in rodents. Anesthesiology 85 6 (1996) 1357-1366
36. Sorensen J., Kalman S., Tropp H., and Bengtsson M. Can a pharmacological pain analysis be used in the assessment of chronic low back pain?. Eur Spine J 5 4 (1996) 236-242
37. Sorensen J., Bengtsson A., Ahlner J., Henriksson K.G., Ekselius L., and Bengtsson M. Fibromyalgia - are there different mechanisms in the processing of pain? A double blind crossover comparison of analgesic drugs. J Rheumatol 24 8 (1997) 1615-1621
38. Sorensen J., Graven-Nielsen T., Henriksson K.G., Bengtsson M., and Arendt-Nielsen L. Hyperexcitability in fibromyalgia. J Rheumatol 25 1 (1998) 152-155
39. Spitzer W.O., Skovron M.L., Salmi L.R., et al. Scientific monograph of the Quebec Task Force on Whiplash-Associated Disorders: redefining "whiplash" and its management. Spine 20 8 Suppl. (1995) 1S-73S
40. Sterner Y., and Gerdle B. Acute and chronic whiplash disorders - a review. J Rehabil Med 36 5 (2004) 193-209 [quiz 210]
41. Stubhaug A., and Breivik H. Long-term treatment of chronic neuropathic pain with the NMDA (N-methyl-d-aspartate) receptor antagonist ketamine. Acta Anaesthesiol Scand 41 3 (1997) 329-331
42. Stubhaug A., Breivik H., Eide P.K., Kreunen M., and Foss A. Mapping of punctuate hyperalgesia around a surgical incision demonstrates that ketamine is a powerful suppressor of central sensitization to pain following surgery. Acta Anaesthesiol Scand 41 9 (1997) 1124-1132
43. Vinik H.R., and Kissin I. Rapid development of tolerance to analgesia during remifentanil infusion in humans. Anesth Analg 86 6 (1998) 1307-1311
44. Yamamoto T., and Yaksh T.L. Studies on the spinal interaction of morphine and the NMDA antagonist MK-801 on the hyperesthesia observed in a rat model of sciatic mononeuropathy. Neurosci Lett 135 1 (1992) 67-70